A PHASE 3, MULTI-NATIONAL, DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED, STRATIFIED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF TIRASEMTIV IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)
Principal Investigator(s)
Jackson,Carlayne E
Funded by
CYTOKINETICS
Research Start Date
Status
Active